Aquestive Therapeutics, Inc. AQST Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Aquestive Therapeutics, Inc. (AQST) reported comprehensive income (loss), net of tax, attributable to parent of -$8.06M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Aquestive Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent increased by 64.9% year-over-year, from -$22.93M to -$8.06M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Aquestive Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a 4.4% compound annual growth rate (CAGR), from -$70.54M to -$83.78M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric represents the total change in equity from non-owner sources, including net income and other gains or losses that bypass the traditional income statement. It provides a comprehensive view of the company's financial performance by accounting for items like foreign currency translation adjustments and unrealized gains on securities. It is a critical indicator of the overall change in the company's net worth during the period.